Chanlu Xie

431 total citations
15 papers, 343 citations indexed

About

Chanlu Xie is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Chanlu Xie has authored 15 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 3 papers in Pharmacology and 3 papers in Oncology. Recurrent topics in Chanlu Xie's work include Ubiquitin and proteasome pathways (7 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Chanlu Xie is often cited by papers focused on Ubiquitin and proteasome pathways (7 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Chanlu Xie collaborates with scholars based in Australia, China and Hong Kong. Chanlu Xie's co-authors include Qihan Dong, Yao Mu, Paul de Souza, Jeff Holst, Zhong Li, Alan Bensoussan, Tao Liu, Hong‐Xi Xu, Zhichao Xi and Ling Bi and has published in prestigious journals such as Journal of Nutrition, International Journal of Cancer and Journal of Ethnopharmacology.

In The Last Decade

Chanlu Xie

15 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chanlu Xie Australia	12	224	125	64	47	33	15	343
Arnatchai Maiuthed Thailand	12	187 0.8×	97 0.8×	83 1.3×	48 1.0×	22 0.7×	22	341
Aloran Mazumder South Korea	13	279 1.2×	96 0.8×	65 1.0×	27 0.6×	24 0.7×	25	435
Peace Mabeta South Africa	10	197 0.9×	105 0.8×	58 0.9×	23 0.5×	25 0.8×	23	383
An‐Chi Tsai Taiwan	10	267 1.2×	77 0.6×	60 0.9×	65 1.4×	41 1.2×	12	384
Roberta R. Ruela-de-Sousa Brazil	11	382 1.7×	99 0.8×	50 0.8×	85 1.8×	38 1.2×	12	556
Jessica Plati United States	6	354 1.6×	112 0.9×	102 1.6×	30 0.6×	32 1.0×	8	521
Xinxian Weng China	9	165 0.7×	97 0.8×	53 0.8×	83 1.8×	29 0.9×	14	306
Jianyang Hu China	11	354 1.6×	92 0.7×	100 1.6×	35 0.7×	46 1.4×	16	511
Brian C. Grieb United States	10	401 1.8×	148 1.2×	74 1.2×	90 1.9×	31 0.9×	16	561
Lingyuan Xu China	9	180 0.8×	159 1.3×	49 0.8×	22 0.5×	60 1.8×	11	397

Countries citing papers authored by Chanlu Xie

Since Specialization

Citations

This map shows the geographic impact of Chanlu Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chanlu Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chanlu Xie more than expected).

Fields of papers citing papers by Chanlu Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chanlu Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chanlu Xie. The network helps show where Chanlu Xie may publish in the future.

Co-authorship network of co-authors of Chanlu Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Chanlu Xie. A scholar is included among the top collaborators of Chanlu Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chanlu Xie. Chanlu Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Mu, Yao, Chanlu Xie, Ling Bi, et al.. (2022). Apigenin impedes cell cycle progression at G2 phase in prostate cancer cells. Discover Oncology. 13(1). 44–44. 11 indexed citations

Lai, Felcia, Chanlu Xie, Yang Zhao, et al.. (2021). Ceramide Regulates Anti-Tumor Mechanisms of Erianin in Androgen-Sensitive and Castration-Resistant Prostate Cancers. Frontiers in Oncology. 11. 738078–738078. 14 indexed citations

Bi, Ling, Chanlu Xie, Yao Mu, et al.. (2021). Agrimol B present in Agrimonia pilosa Ledeb impedes cell cycle progression of cancer cells through G0 state arrest. Biomedicine & Pharmacotherapy. 141. 111795–111795. 23 indexed citations

Bi, Ling, Chanlu Xie, Lijing Jiao, et al.. (2020). CPF impedes cell cycle re‐entry of quiescent lung cancer cells through transcriptional suppression of FACT and c‐MYC. Journal of Cellular and Molecular Medicine. 24(3). 2229–2239. 8 indexed citations

Mu, Yao, Chanlu Xie, Guang‐Bo Ge, et al.. (2019). Transcriptional regulation of G2/M regulatory proteins and perturbation of G2/M Cell cycle transition by a traditional Chinese medicine recipe. Journal of Ethnopharmacology. 251. 112526–112526. 24 indexed citations

Bi, Ling, Chanlu Xie, Yao Mu, et al.. (2018). The histone chaperone complex FACT promotes proliferative switch of G₀ cancer cells. International Journal of Cancer. 145(1). 164–178. 23 indexed citations

Xi, Zhichao, Yao Mu, Yang Li, et al.. (2016). Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation. Cell Death and Disease. 7(6). e2252–e2252. 36 indexed citations

Shen, Kaikai, Zhichao Xi, Jianling Xie, et al.. (2016). Guttiferone K suppresses cell motility and metastasis of hepatocellular carcinoma by restoring aberrantly reduced profilin 1. Oncotarget. 7(35). 56650–56663. 27 indexed citations

Mu, Yao, et al.. (2015). AKT and cytosolic phospholipase A<sub>2</sub>α form a positive loop in prostate cancer cells. Current Cancer Drug Targets. 15(9). 781–791. 8 indexed citations

10.

Xie, Chanlu, Yao Mu, Jeff Holst, et al.. (2015). p27Kip1 signaling: Transcriptional and post-translational regulation. The International Journal of Biochemistry & Cell Biology. 68. 9–14. 86 indexed citations

11.

Mu, Yao, Chanlu Xie, Ying Teng, et al.. (2015). Targeting of cytosolic phospholipase A2α impedes cell cycle re-entry of quiescent prostate cancer cells. Oncotarget. 6(33). 34458–34474. 13 indexed citations

12.

Zheng, Zhong, Xiangyi He, Chanlu Xie, et al.. (2014). Targeting cytosolic phospholipase A2 α in colorectal cancer cells inhibits constitutively activated protein kinase B (AKT) and cell proliferation. Oncotarget. 5(23). 12304–12316. 16 indexed citations

13.

Xie, Chanlu, Yao Mu, Yuting Sun, et al.. (2014). Loss of PTEN stabilizes the lipid modifying enzyme cytosolic phospholipase A2α via AKT in prostate cancer cells. Oncotarget. 5(15). 6289–6299. 17 indexed citations

14.

Garbutcheon‐Singh, K. Benjamin, Simon J. Myers, Benjamin W. J. Harper, et al.. (2013). The effects of 56MESS on mitochondrial and cytoskeletal proteins and the cell cycle in MDCK cells. Metallomics. 5(8). 1061–1061. 32 indexed citations

15.

Singh, Jaskirat, Chanlu Xie, Yao Mu, et al.. (2010). Food Extracts Consumed in Mediterranean Countries and East Asia Reduce Protein Concentrations of Androgen Receptor, Phospho-Protein Kinase B, and Phospho-Cytosolic Phospholipase A2α in Human Prostate Cancer Cells. Journal of Nutrition. 140(4). 786–791. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact